High Court Passes On Lilly's $20M Cialis Patent Loss
Eli Lilly & Co. is stuck with a $20 million verdict for infringing a German company's patent with its Cialis marketing practices after the U.S. Supreme Court on Monday refused to hear...To view the full article, register now.
Already a subscriber? Click here to view full article